Company Info
Phone(617) 401-4499
Year Established
2003
Ticker
MRUS
Exchange
NASDAQ
Contacts
Hui Liu, Ph.D.CBO & Head of Merus U.S.
Bill Lundberg, M.D.
President & CEO
Andrew Joe, M.D.
CMO
Peter B. Silverman, J.D.
General Counsel & COO
Shannon Campbell
CCO
John de Kruif, Ph.D.
CTO
Cecile Geuijen, Ph.D.
CSO
Greg Perry
CFO
Company Description
Merus is a clinical-stage oncology company developing innovative full-length human bispecific and trispecific antibody therapeutics, referred to as Multiclonicsﾮ.
